PharmAthene, Inc. (ALT)

Last Year

26-Nov-23 -- 25-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Diversified Investments

Financial Services

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

33

0

7

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Aug-24 6:05 PM View:	19-Aug-24 Option Sale ($110.55K)	Drutz David Director		PharmAthene, Inc. - ALT	86% 29.79K to 55.52K	0	0	--	--	Show Txns Hide Txns

01-Aug-24 5:45 PM View:	31-Jul-24 Grant $3.52K	Roberts M Scot Chief Scientific Officer		PharmAthene, Inc. - ALT	112% 20.44K to 43.33K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 6:00 PM View:	02-Feb-24 Payment of Exercise ($78.06K)	Garg Vipin K President and CEO Director		PharmAthene, Inc. - ALT	17% 249.25K to 292.03K	0	0	--	--	Show Txns Hide Txns

01-Aug-24 5:40 PM View:	31-Jul-24 Grant $8.04K	Harris Matthew Scott Chief Medical Officer		PharmAthene, Inc. - ALT	62% 34.0K to 55.12K	0	0	--	--	Show Txns Hide Txns

01-Feb-24 6:00 PM View:	31-Jan-24 Grant $12.43K	Eisenstadt Richard I Chief Financial Officer		PharmAthene, Inc. - ALT	89% 23.84K to 45.01K	0	0	--	--	Show Txns Hide Txns

01-Aug-24 5:43 PM View:	31-Jul-24 Grant $4.96K	Jordt Raymond M Chief Business Officer		PharmAthene, Inc. - ALT	700% 1.83K to 14.66K	0	0	--	--	Show Txns Hide Txns

01-Aug-24 5:47 PM View:	31-Jul-24 Grant $6.81K	Shutterly Andrew Acting Chief Financial Officer		PharmAthene, Inc. - ALT	12% 10.11K to 11.37K	0	0	--	--	Show Txns Hide Txns